Clinical Trial

Clinical Trial to Evaluate the Safety, Pharmacokinetic Characteristics of DW5124 and DW5124-R, and the Effect of Food on DW5124 in Healthy Adult Volunteers

Name: Clinical Trial to Evaluate the Safety, Pharmacokinetic Characteristics of DW5124 and DW5124-R, and the Effect of Food on DW5124 in Healthy Adult Volunteers — clinical trial record (NCT07319559)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 1

View on ClinicalTrials.gov →

Summary

This study aimed to evaluate the safety and pharmacokinetic characteristics of DW5124 and DW5124-R, and the effect of food on DW5124, in healthy adult volunteers.

Trial Details

NCT Number	NCT07319559
Lead Sponsor	Daewon Pharmaceutical Co., Ltd.
Conditions	Mixed Dyslipidemia
Enrollment	55 participants
Start Date	2025-05-08
Primary Completion	2025-05-11 (estimated)
Study Completion	2025-06-05 (estimated)
Updated on ClinicalTrials.gov	2026-01-06